← Back to Search

Behavioral Intervention

Bias Reduction Training for Pharmacists Prescribing PrEP

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will use a model called ADAPT-ITT to apply a Prejudice Habit Breaking Intervention to pharmacists who have experience with or are willing to prescribe PrEP. The study will collect qualitative

Who is the study for?
This trial is for pharmacists who have experience with or are open to prescribing PrEP, a medication that helps prevent HIV. The study aims to train them to reduce implicit racial bias in their service.
What is being tested?
The study tests two interventions: the NIH Implicit Bias course and an adapted version of the Prejudice Habit Breaking Intervention (PHBI). It will assess how these can help pharmacists serve patients more equitably.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience changes in attitudes or beliefs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the adapted intervention- Questionnaire
Feasibility of the adapted intervention- Observed length of recruitment time
Feasibility of the adapted intervention- Questionnaire
+2 more
Secondary study objectives
Concern about discrimination
Reduction of implicit racial bias

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: The adapted PHBIExperimental Treatment1 Intervention
The intervention group will be given access to the adapted PHBI.
Group II: NIH Implicit Bias courseActive Control1 Intervention
The control group will be instructed to take the course, "NIH Implicit Bias".

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,729 Total Patients Enrolled
~47 spots leftby Jan 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top